Literature DB >> 17786230

MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets.

Eva van Rooij1, Eric N Olson.   

Abstract

MicroRNAs act as negative regulators of gene expression by inhibiting the translation or promoting the degradation of target mRNAs. Recent studies have revealed key roles of microRNAs as regulators of the growth, development, function, and stress responsiveness of the heart, providing glimpses of undiscovered regulatory mechanisms and potential therapeutic targets for the treatment of heart disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786230      PMCID: PMC1952642          DOI: 10.1172/JCI33099

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

1.  The Microprocessor complex mediates the genesis of microRNAs.

Authors:  Richard I Gregory; Kai-Ping Yan; Govindasamy Amuthan; Thimmaiah Chendrimada; Behzad Doratotaj; Neil Cooch; Ramin Shiekhattar
Journal:  Nature       Date:  2004-11-07       Impact factor: 49.962

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

3.  Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND.

Authors:  D Srivastava; T Thomas; Q Lin; M L Kirby; D Brown; E N Olson
Journal:  Nat Genet       Date:  1997-06       Impact factor: 38.330

Review 4.  Incidence of congenital heart disease: II. Prenatal incidence.

Authors:  J I Hoffman
Journal:  Pediatr Cardiol       Date:  1995 Jul-Aug       Impact factor: 1.655

5.  Myosin heavy chain gene expression in human heart failure.

Authors:  K Nakao; W Minobe; R Roden; M R Bristow; L A Leinwand
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

6.  Impact of beta-myosin heavy chain expression on cardiac function during stress.

Authors:  Maike Krenz; Jeffrey Robbins
Journal:  J Am Coll Cardiol       Date:  2004-12-21       Impact factor: 24.094

7.  Processing of primary microRNAs by the Microprocessor complex.

Authors:  Ahmet M Denli; Bastiaan B J Tops; Ronald H A Plasterk; René F Ketting; Gregory J Hannon
Journal:  Nature       Date:  2004-11-07       Impact factor: 49.962

8.  Influence of thyroid status on the differentiation of slow and fast muscle phenotypes.

Authors:  A Vadászová; G Zacharová; K Machácová; I Jirmanová; T Soukup
Journal:  Physiol Res       Date:  2004       Impact factor: 1.881

9.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

10.  MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts.

Authors:  Jiening Xiao; Xiaobin Luo; Huixian Lin; Ying Zhang; Yanjie Lu; Ning Wang; Yiqiang Zhang; Baofeng Yang; Zhiguo Wang
Journal:  J Biol Chem       Date:  2007-03-07       Impact factor: 5.157

View more
  229 in total

1.  Circulating and renal vein levels of microRNAs in patients with renal artery stenosis.

Authors:  Moo Yong Park; Sandra M Herrmann; Ahmed Saad; Robert Jay Widmer; Hui Tang; Xiang-Yang Zhu; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Nephrol Dial Transplant       Date:  2014-10-31       Impact factor: 5.992

Review 2.  Horizontal transfer of microRNAs: molecular mechanisms and clinical applications.

Authors:  Xi Chen; Hongwei Liang; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Protein Cell       Date:  2012-02-09       Impact factor: 14.870

3.  MicroRNAs: Novel Regulators of the Heart.

Authors:  Junjie Xiao; Yi-Han Chen
Journal:  J Thorac Dis       Date:  2010-03       Impact factor: 2.895

Review 4.  Vascular smooth muscle phenotypic diversity and function.

Authors:  Steven A Fisher
Journal:  Physiol Genomics       Date:  2010-08-24       Impact factor: 3.107

5.  MicroRNAs as new players in the genomic galaxy and disease puzzles.

Authors:  Elisa Barbarotto; Paola Secchiero; Abhijit Dasgupta; Paolo Fortina; George A Calin; Terry Hyslop
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

6.  Affinity purification of microRNA-133a with the cardiac transcription factor, Hand2.

Authors:  Ngan K Vo; Ryan P Dalton; Ning Liu; Eric N Olson; Richard H Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

7.  miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart.

Authors:  Walter A Baseler; Dharendra Thapa; Rajaganapathi Jagannathan; Erinne R Dabkowski; Tara L Croston; John M Hollander
Journal:  Am J Physiol Cell Physiol       Date:  2012-10-03       Impact factor: 4.249

8.  Searching for miR-acles in cardiac fibrosis.

Authors:  Eva van Rooij; Eric N Olson
Journal:  Circ Res       Date:  2009-01-30       Impact factor: 17.367

9.  Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a.

Authors:  Jonathan D Verrier; Pierre Lau; Lynn Hudson; Alexander K Murashov; Rolf Renne; Lucia Notterpek
Journal:  Glia       Date:  2009-09       Impact factor: 7.452

10.  MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice.

Authors:  Andrew H Williams; Gregorio Valdez; Viviana Moresi; Xiaoxia Qi; John McAnally; Jeffrey L Elliott; Rhonda Bassel-Duby; Joshua R Sanes; Eric N Olson
Journal:  Science       Date:  2009-12-11       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.